Not sure where to start? Get matched →
How it worksBlood TestingDaily PackPepti OnePepti PenCreator PartnershipsAccountGet started →

— Lab results

Every lot, tested. Every result, published.

Each medication lot dispensed through Pepti is tested by an independent laboratory before the pharmacy releases it. The results below are transcribed from the laboratory's certificate for each lot, with the original attached where available. Testing lab: Eagle Analytical Services Inc., Houston, TX.

What is and isn't on a given report: sterility and endotoxin are on 5 and 5 of 5 lots respectively; potency on 5; purity on 0; identity on 0. A blank cell means that test was not run on that lot, not that it failed.

Last updated September 2, 20265 lots across 5 medications

Lot 1633842

BPC-157 3000mcg Injection Solution — CARTRIDGE

Tested September 2, 2026 by Eagle Analytical Services Inc., Houston, TX · Compounded by Mills Pharmacy & Apothecary, Birmingham, MI

Sterility

Pass

ScanRDI rapid sterility

Bacterial endotoxins

< 2 EU/mL

USP <85> · spec limit 1500 EU/mL

Potency

105.3% of label — 3159 mcg/mL measured vs 3000 mcg/mL label

USP <621>

Purity

Not tested on this lot

Identity

Not tested on this lot

pH

Not tested on this lot

Particulate matter

Not tested on this lot

Container closure integrity

Not tested on this lot

Eagle submission ETX-260819-0481, sample received 8/20/2026. Potency tested 9/1–9/2/2026, sterility 8/20–8/25/2026, endotoxin 8/21–8/22/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."

BPC-157 + TB-500

Product page →

Lot 1634586

Wolverine — BPC-157 3000mcg / TB-500 4500mcg/mL Injection Solution

Tested September 2, 2026 by Eagle Analytical Services Inc., Houston, TX · Compounded by Mills Pharmacy & Apothecary, Birmingham, MI

Sterility

Pass

ScanRDI rapid sterility

Bacterial endotoxins

5.06 EU/mL

USP <85> · spec limit 1500 EU/mL

Potency

BPC-157 100.9% (3027 mcg/mL vs 3000 label) · TB-500 105.0% (4725 mcg/mL vs 4500 label)

USP <621>, each peptide assayed separately

Purity

Not tested on this lot

Identity

Not tested on this lot

pH

Not tested on this lot

Particulate matter

Not tested on this lot

Container closure integrity

Not tested on this lot

Eagle submission ETX-260821-0428, sample received 8/25/2026. Potency tested 9/1–9/2/2026, sterility 8/25–8/26/2026, endotoxin 8/26–8/27/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."

CJC-1295 / Ipamorelin / Sermorelin

Product page →

Lot 1633841

CJC-1295 (500mcg) / Ipamorelin Acetate (2000mcg) / Sermorelin Acetate (2000mcg) — CARTS

Tested August 31, 2026 by Eagle Analytical Services Inc., Houston, TX · Compounded by Mills Pharmacy & Apothecary, Birmingham, MI

Sterility

Pass (Day 7)

Celsis rapid sterility, direct inoculation

Bacterial endotoxins

< 2 EU/mL

USP <85> · spec limit 700 EU/mL

Potency

CJC-1295 99.4% (497 mcg/mL vs 500 label) · Ipamorelin acetate 103.6% (2072 mcg/mL vs 2000 label) · Sermorelin acetate 99.9% (1998 mcg/mL vs 2000 label)

USP <621>, each peptide assayed separately

Purity

Not tested on this lot

Identity

Not tested on this lot

pH

Not tested on this lot

Particulate matter

Not tested on this lot

Container closure integrity

Not tested on this lot

Eagle submission ETX-260819-0521, sample received 8/20/2026. Potency tested 8/28–8/31/2026, sterility 8/20–8/28/2026, endotoxin 8/21–8/22/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."

NAD+ Injection

Product page →

Lot 1629756

NAD+ 200mg/mL in 3.1mL Cartridges

Tested August 17, 2026 by Eagle Analytical Services Inc., Houston, TX · Compounded by Mills Pharmacy & Apothecary, Birmingham, MI

Sterility

Pass

ScanRDI rapid sterility

Bacterial endotoxins

< 2 EU/mL

USP <85> · spec limit 350 EU/mL

Potency

95.0% of label — 190 mg/mL measured vs 200 mg/mL label

USP <621>

Purity

Not tested on this lot

Identity

Not tested on this lot

pH

Not tested on this lot

Particulate matter

Not tested on this lot

Container closure integrity

Not tested on this lot

Eagle submission ETX-260805-0452, sample received 8/6/2026. Potency tested 8/13–8/17/2026, sterility 8/6–8/8/2026, endotoxin 8/7–8/8/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."

Lot 1627989

Sermorelin (3mg/mL) Subcutaneous Cartridge Solution

Tested August 11, 2026 by Eagle Analytical Services Inc., Houston, TX · Compounded by Mills Pharmacy & Apothecary, Birmingham, MI

Sterility

Pass (Day 7)

Celsis rapid sterility, direct inoculation

Bacterial endotoxins

< 2 EU/mL

USP <85> · spec limit 1500 EU/mL

Potency

90.7% of label — 2.72 mg/mL measured vs 3.00 mg/mL label

USP <621>

Purity

Not tested on this lot

Identity

Not tested on this lot

pH

Not tested on this lot

Particulate matter

Not tested on this lot

Container closure integrity

Not tested on this lot

Eagle submission ETX-260729-0250, sample received 7/30/2026. Potency tested 8/10–8/11/2026, sterility 7/31–8/7/2026, endotoxin 7/31–8/3/2026. The report prints no acceptance range for potency. Lab disclaimer on potency: "The potency method(s) used for testing passed system suitability requirements per Eagle SOP 2.500.001. Product-specific method validation is not available for this sample."
Results are transcribed from the testing laboratory's certificate of analysis for the specific lot shown and apply to that lot only. Compounded medications are not FDA-approved. A licensed physician determines whether treatment is appropriate for each patient. See how Pepti prescriptions are filled.
Important legal & safety information

The assessment process available on the Pepti website asks a series of medical questions, and the answers provided are reviewed by an independent licensed physician affiliated with our partner physician network. The licensed providers have established exclusionary criteria, and the answers provided determine if the individual is screened out of eligibility for treatment. The licensed clinicians retain the sole decision to prescribe peptide therapy and other compounded medications to patients. Treatment may be denied at the physician's sole discretion. If a prescription is not approved, you will not be charged for the medication.

Pharmacy Providers. Pepti is a technology platform and is not a healthcare provider, pharmacy, or prescriber. All medications offered through the platform are compounded by independent FDA-registered 503A or 503B compounding pharmacies based on a valid prescription written by a licensed physician for an individual patient. Compounded medications are not FDA-approved as products. The active pharmaceutical ingredients used by our partner pharmacies are sourced from FDA-registered facilities. Compounded medications may not undergo the same testing or quality control as commercially manufactured FDA-approved drugs.

Results vary. Results from peptide therapy and other compounded treatments vary based on individual factors, including age, weight, medical history, adherence to the prescribed protocol, lifestyle factors, and physiological response. Pepti makes no guarantee of any specific outcome. Statements about peptide therapy and compounded medications offered through the platform have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Product images. Product photographs and renderings shown on this website are for illustrative purposes only. The appearance of vials, packaging, labeling, and other materials you receive may vary and is determined by the dispensing compounding pharmacy.

Off-label use.Many peptides offered through the platform are prescribed for off-label use. “Off-label” means the medication is being prescribed for a use, dose, or patient population that is not specifically approved by the FDA. Off-label prescribing is legal and common in U.S. medical practice when supported by clinical experience and judgment.

Mailing & shipping. Pepti currently dispenses prescription medication to patients in all 50 states and Washington, D.C.. All orders ship in unbranded, tamper-evident packaging via expedited delivery from our partner compounding pharmacies. Temperature-sensitive medications ship with insulated packaging and ice packs. Shipping is included at no additional cost. We do not currently ship medication outside all 50 states and Washington, D.C., internationally, or to APO/FPO addresses.

Not for emergencies. Pepti is not designed for medical emergencies. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately. For urgent but non-emergency medical questions, contact your primary care provider or use an urgent care service.

No doctor-patient relationship with Pepti. Your use of the platform does not create a doctor-patient relationship between you and pepti LLC. A doctor-patient relationship is established only between you and the independent licensed physician who reviews your intake and prescribes your treatment. The physicians who use the platform are independent contractors and are solely responsible for the medical care they provide.

Prescription medications. All prescription products require a valid prescription from a licensed healthcare provider. By using the platform, you acknowledge that you are at least 18 years old and that the information you provide is true, accurate, current, and complete. Providing false information may result in inappropriate treatment recommendations or denial of service.

Cosmetic & wellness products.Certain products offered through Pepti — including skincare, hair care, body care, supplements, men's grooming, sports recovery, and sexual wellness products — are cosmetic or dietary supplement products, not prescription medications. These products do not require a prescription and are not reviewed or prescribed by a physician. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Results vary by individual. Consult your healthcare provider before starting any new supplement or topical product, especially if you are pregnant, nursing, or taking other medications.

pepti LLC · Delaware Limited Liability Company · 131 Continental Dr, Suite 305, Newark, DE 19713 · For media or partnership inquiries, email hello@hellopepti.com. For patient support, email support@hellopepti.com. For privacy and HIPAA inquiries, email privacy@hellopepti.com.